Press Releases
Search by Year
-
16 Apr 2020
First-Quarter 2020 Business Review
bioMérieux fully mobilized against COVID-19 epidemic Organic growth of more than 20% at constant exchange rates and scope of consolidation over the first quarter: €769 million in sales Up 21.5% as rep...
-
09 Apr 2020
bioMérieux’s Annual General Meeting postponed
Due to the unprecedented circumstances linked to the COVID-19 pandemic, the Board of Directors of bioMérieux, which met today, has decided to postpone the Annual General Meeting initially scheduled on...
-
24 Mar 2020
bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration...
-
11 Mar 2020
First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMérieux
bioMérieux, a world leader in the field of in vitro diagnostics, is announcing the forthcoming launch of 3 different tests to address the COVID-19 epidemic and to meet the different needs of physician...
-
26 Feb 2020
2019 Financial Results
€2,675 million in sales for full-year 2019, representing a reported increase of 10.5% and organic growth of 7.2% Strong sales momentum in the fourth quarter, with organic growth of 8.3% driven by sale...
-
26 Feb 2020
Financial Information
Résultats annuels au 31 décembre 2019
Chiffre d’affaires 2019 de 2 675 millions d’euros, en hausse de 10,5 % à données publiées, soit une croissance organique de 7,2 % Solide dynamique commerciale au 4e trimestre, avec une croissance orga...
-
13 Jan 2020
bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...
-
18 Dec 2019
bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries
London (UK), Marcy l’Étoile (France) – December 18, 2019 – bioMérieux, a world leader in in vitro diagnostics which develops and manufactures testing solutions (systems, reagents, software, services) ...
-
22 Oct 2019
Third-Quarter 2019 Business Review
Organic growth of 6.8% at constant exchange rates and scope of consolidation over the first nine months of the year: €1,928 million in sales Up 10.3% as reported Acceleration of organic growth in sale...
-
04 Sep 2019
First-Half 2019 Results
bioMérieux – First-Half 2019 Results Organic sales growth of 5.5% for first-half 2019: €1,275 million in sales Up 9.1% as reported As expected, growth accelerated in the second quarter, up to 7.4% at ...